J&J to break ground on new biologics facility in North Carolina
New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases
New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases
Dimethyl Fumarate Modified Release Capsules are indicated for the treatment of relapsing forms of multiple sclerosis
Previously, Sujatha has held leadership positions at prominent organizations, including Publicis Sapient, Infinite Computer Solutions, and Capgemini
The new office in New Delhi marks a significant funding in the APAC region and reinforces the company’s commitment to advancing respiratory care in India
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Experts urge early detection & better access to care
Subscribe To Our Newsletter & Stay Updated